Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ads free!Spring sale! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ads free today!Spring sale! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Genentech
Pharmaceuticals
Moderna
Gilead Sciences
Topics

Advertisement

Genentech

Share

Top Latest Popular

Earlier Today

Genentech, TD Bank innovation leaders reveal why they back AI defensive patent organisation IAM 14:12

Yesterday

FARE Introduces Its Newest PSA, "Empower Yourself, Empower Each Other," Featuring Actor, Food Allergy Patient and FARE Volunteer Ambassador Joshua Jackson PR Newswire (Press Release) 12:02 Thu, 07 May

In the last month

Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at Arvo 2026 Business Wire (Press Release) 06:01 Thu, 30 Apr

Advertisement

Advertisement

Damon Wayans Urges Fans Not to Ignore This Hidden Diabetes Risk (Exclusive) The Tribune, California 00:26 Sat, 25 Apr

Genentech wants ‘All Eyes on DME’ as it taps Damon Wayans for humor-laced campaign FiercePharma 14:47 Fri, 24 Apr

Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on Dme’ Campaign Business Wire (Press Release) 13:04 Fri, 24 Apr

Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS Business Wire (Press Release) 00:23 Wed, 22 Apr

Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for Mogad Business Wire (Press Release) 16:54 Tue, 21 Apr

Correcting and replacing FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Business Wire (Press Release) 07:53 Tue, 21 Apr

FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus Business Wire (Press Release) 06:02 Tue, 21 Apr

Genentech shifts Hemlibra marketing focus to patient stories as competition approaches FiercePharma 19:23 Mon, 20 Apr

More Drugmakers Join TrumpRx Endocrinology Advisor 14:44 Fri, 10 Apr

TrumpRx Expands as AbbVie, Genentech Join Drug Plan Effort NewsMax 23:31 Tue, 07 Apr

Advertisement

Advertisement

Genentech News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Genentech news, covering the latest share price, company announcements, product trials, biotechnology news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis